TELEGRAFT -- The International Society for Cellular Therapy newsletter cited MARK ROBERTS's "particularly interesting" demonstration of emergent disease modeling using Pitt Public Health's FRED (Framework for Reconstructing Epidemiological Dynamics) at the FDA workshop on "Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products."
FORBES - Young mothers are being prescribed opioid painkillers, placing their children—even those less than a year old—at risk for an overdose.
A study in the journal Obstetrics & Gynecology co-authored by HPM's MARIAN JARLENSKI found that 12% of women filled a prescription for an opioid within five days of their baby’s birth....[Of them] 14% filled a second opioid prescription 6 to 60 days after delivery.
POETS & QUANTS - In an uncertain healthcare landscape, the two schools are teaming up to address an overwhelming national need for quality health care managers. “The synthesis between the two areas is pretty important, because of the increased competitiveness in health care and the uncertainty of federal funding programs,” says WES ROHRER, director of the MHA program. Says department chair Mark Roberts, “From the business school, it’s hard to i...
U.S.NEWS - Speaking from experience, HPM Chair MARK ROBERTS says there are lots of things doctors can do beside taking care of patients. A nonclinical route as medical researcher allows those with a passion for innovation to have enormous influence on the future by discovering a drug or increasing understanding of a disease.
PHILADELPHIA INQUIRER - "There are many guidelines for managing acute or chronic pain, but not for maternity care," said lead author MARIAN JARLENSKI, a Pitt health-policy researcher. "We have a public health crisis with opioid addiction. We were surprised to see more than 1 in 10 women were going home with an opioid prescription."
90.5 WESA - As an organizer with the group Pittsburgh Lead Action Now, doctoral student BETH SHAABAN (EPI '18) is seeking to find solutions to the city’s lead issue. "We’d like to see the process be very transparent so that we can help monitor what’s going on,” she said. Shaaban and fellow students Abigail Cartus (EPI '20) and Ray Van Cleve (HPM) are among the community members who have been instrumental to the group's organizing committee.
NPR - The only government report that looks at the issue concluded that it would have a "negligible effect" on prices, but WALLID GELLAD of HPM disagrees. "There's a reason why the pharmaceutical industry does not want Medicare negotiation to happen, and the obvious reason is because it will lower prices."
OUTLOUD - Chase Brexton Health Care’s board announced the hiring of PATRICK MUTCH (HADM '78) as the organization’s new president and CEO. “We were impressed by Patrick’s deep understanding of our welcoming, affirming, patient-focused care,” said board chair Carolyn Kennedy. “He possesses a wealth of experience in both non-profit and for-profit health care systems, and understands how to lead and develop integrated care models.”
NEW YORK TIMES - “I don’t think public health officials should be alarming people,” said MARIAN JARLENSKI, the study’s lead author and an assistant professor of Health Policy and Management at Pitt Public Health. “They just have to say, ‘There have been studies done, and there is some risk.’”
MARKETPLACE - In a Marketplace interview about insulin drugmakers accused of price fixing, WALID GELLAD (HPM) said, “They’re competing on the price that the pharmacy benefit manager and the insurer pays. They're not competing on the price that the patient pays."
TRIB LIVE - HPM Chair MARK ROBERTS was asked to weigh in on the tremendous economic benefits to a community when public health clinics offer vaccinations. In a city such as Pittsburgh, where there are no public hospitals, public clinics become even more crucial.
NEW YORK TIMES - When interviewed, HPM's NICHOLAS CASTLE voices concern about staff turnover and chronic underfunding.
KAISER HEALTH NEWS - Co-director of the Pitt's Center for Pharmaceutical Policy and Prescribing, HPM's JULIE DONOHUE said Medicare’s use of step therapy is one of the few tools it has to contain soaring drug costs. “Unfortunately, unfettered choice of medicines … leads to higher drug spending and higher cost for taxpayers, so you have to strike the right balance.”
HEALTHCARE FINANCE - After more than a decade, ROBERT HENKEL (HPM '82) will retire from Ascension, the country's largest faith-based nonprofit healthcare system, on July 1, officially stepping down as executive vice president of Ascension, and president and CEO of Ascension Healthcare...
Those roles will be filled by PATRICIA MARYLAND (HPM '82) who will assume responsibility for Ascension's Healthcare Division, encompassing more than 141 hos...
BLOOMBERG - Pitt's head of the Center for Pharmaceutical Policy and Prescribing, WALID GELLAD (HPM) says ‘‘It may just be setting a starting point for negotiations and then using that for negotiations later in the ACA. You’re not going to get the support of the pharmaceutical industry if you’re talking about reducing their revenue.”